- STAT+: Popular insulin product enters shortage as other pens leave marketThe Lantus Solostar insulin pen isn't in official FDA shortage, but patients are having a tough time finding it.STAT · 23h ago↗ source
- Senate health panel delays vote on CDC nomineeToo few senators were in attendance to proceed with a vote on the CDC director nominee.STAT · 23h ago↗ source
- Sartorius reduces revenue by €26M to refund Trump tariffs to customersSartorius appears to be the first life science company to detail how tariff refunds are affecting its revenue, following the US Supreme Court decision to block some of President Donald Trump’s levi…Endpoints · 1d ago↗ source